Amiodarone HCl Injection
FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease »
"The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked a"...
Read the FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease article »
Amiodarone HCl Injection
Amiodarone HCl Injection
For Intravenous Use Only
DRUG DESCRIPTION
Amiodarone HCl Injection contains amiodarone HCl (C25H29I2NO3•HCl), a class III antiarrhythmic drug. Amiodarone HCl is (2-butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone hydrochloride. Amiodarone HCl has the following structural formula:
 |
Amiodarone HCl is a white to slightly yellow crystalline powder, and is very slightly soluble in water. It has a molecular weight of 681.78 and contains 37.3% iodine by weight. Amiodarone HCl injection is a sterile clear, pale-yellow micellar solution visually free from particulates. Each milliliter of the amiodarone HCl injection formulation contains 50 mg of amiodarone HCl, 20.2 mg of benzyl alcohol NF, 100 mg of polysorbate 80 NF, and Water for Injection USP.
Last reviewed on RxList: 11/18/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Amiodarone HCl Injection Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Heart Health
Get the latest treatment options.
Updated & New
